This company is no longer active
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Aerie Pharmaceuticals Gestione
Gestione criteri di controllo 1/4
Informazioni chiave
Raj Kannan
Amministratore delegato
US$4.3m
Compenso totale
Percentuale dello stipendio del CEO | 0.6% |
Mandato del CEO | less than a year |
Proprietà del CEO | 0.4% |
Durata media del management | less than a year |
Durata media del Consiglio di amministrazione | 7.4yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Sep 30 2022 | n/a | n/a | -US$37m |
Jun 30 2022 | n/a | n/a | -US$49m |
Mar 31 2022 | n/a | n/a | -US$69m |
Dec 31 2021 | US$4m | US$24k | -US$75m |
Compensazione vs Mercato: Raj's total compensation ($USD4.25M) is above average for companies of similar size in the German market ($USD1.32M).
Compensazione vs guadagni: Insufficient data to compare Raj's compensation with company performance.
AMMINISTRATORE DELEGATO
Raj Kannan (58 yo)
less than a year
Mandato
US$4,253,490
Compensazione
Mr. Raj Kannan serves as Chief Executive Officer and Director at Aerie Pharmaceuticals, Inc since December 20, 2021 and serves as its Principal Financial Officer since March 1, 2022. He has been Chief Exec...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
CEO, Principal Financial Officer & Director | less than a year | US$4.25m | 0.44% $ 3.2m | |
Co-Founder | 17.8yrs | US$1.46m | 0.57% $ 4.2m | |
General Counsel & Secretary | 4.8yrs | US$1.45m | 0.11% $ 797.5k | |
Chief Financial Officer | less than a year | Nessun dato | 0.18% $ 1.3m | |
Head of Clinical Development & Operations | no data | Nessun dato | Nessun dato | |
VP of Finance & Principal Accounting Officer | 3.4yrs | Nessun dato | 0.038% $ 276.6k | |
Senior Director of Communications | 1.2yrs | Nessun dato | Nessun dato | |
Head of Human Resources | less than a year | Nessun dato | Nessun dato | |
Head of Regulatory Affairs & Quality Assurance | less than a year | Nessun dato | Nessun dato | |
Head of Business Development | less than a year | Nessun dato | Nessun dato | |
Head of Manufacturing | less than a year | Nessun dato | Nessun dato | |
Chief Medical Officer | less than a year | Nessun dato | Nessun dato |
0.8yrs
Durata media
57.5yo
Età media
Gestione esperta: 0P0's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
CEO, Principal Financial Officer & Director | less than a year | US$4.25m | 0.44% $ 3.2m | |
Independent Chairman | 8.2yrs | US$1.77m | 0.085% $ 624.9k | |
Independent Director | 4.2yrs | US$168.67k | 0.027% $ 200.8k | |
Independent Director | 7.4yrs | US$163.67k | 0.033% $ 239.6k | |
Independent Director | 2.4yrs | US$161.17k | 0.016% $ 119.0k | |
Independent Director | 7.5yrs | US$169.05k | 0.033% $ 239.6k | |
Independent Director | 7.4yrs | US$173.67k | 0.033% $ 239.6k |
7.4yrs
Durata media
67yo
Età media
Consiglio di amministrazione esperto: 0P0's board of directors are considered experienced (7.4 years average tenure).